An investigation on behalf of investors in ADMA Biologics Inc (NASDAQ:ADMA) shares over potential wrongdoing at ADMA Biologics was announced and NASDAQ:ADMA stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 08/17/2016 -- An investigation for investors in shares of ADMA Biologics Inc (NASDAQ:ADMA) was announced over potential breaches of fiduciary duties by certain officers and directors at ADMA Biologics.
Investors who purchased shares of ADMA Biologics Inc (NASDAQ:ADMA) and currently hold any of those NASDAQ:ADMA shares have certain options and should contact the Shareholders Foundation at email@example.com or call 858-779-1554.
The investigation by a law firm concerns whether certain ADMA Biologics officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
ADMA Biologics Inc reported that its annual Total Revenue rose from $53.07 million in 2013 to $7.18 million in 2015 and that its Net Loss increased from $15.53 million in 2013 to $17.97 million in 2015.
On August 16, 2016, NASDAQ:ADMA shares closed at $5.88 per share.
Those who purchased shares of ADMA Biologics Inc have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego